Evidence map›Paper›PMID 27634179›Full record

ArticleGenome biology2016

An alternative novel tool for DNA editing without target sequence limitation: the structure-guided nuclease.

Shu Xu, Shasha Cao, Bingjie Zou, Yunyun Yue, Chun Gu, Xin Chen, Pei Wang, Xiaohua Dong, Zheng Xiang, Kai Li and 3 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 orAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2018
    Article
  11. Review
  12. Zebrafish Znfl1 proteins control the expression ofThe Journal of biological chemistry · 2017
    Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Shu XuDepartment of Pharmacology, Jinling Hospital, School of Medicine, Nanjing University, No. 305 Zhongshan East Road, Nanjing, 210002, People's Republic of China.
Shasha CaoMOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Nanjing University, 12 Xuefu Road, Pukou High-tech Development Zone, Nanjing, 210061, People's Republic of China.
Bingjie ZouDepartment of Pharmacology, Jinling Hospital, School of Medicine, Nanjing University, No. 305 Zhongshan East Road, Nanjing, 210002, People's Republic of China.
Yunyun YueMOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Nanjing University, 12 Xuefu Road, Pukou High-tech Development Zone, Nanjing, 210061, People's Republic of China.
Chun GuMOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Nanjing University, 12 Xuefu Road, Pukou High-tech Development Zone, Nanjing, 210061, People's Republic of China.
Xin ChenMOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Nanjing University, 12 Xuefu Road, Pukou High-tech Development Zone, Nanjing, 210061, People's Republic of China.
Pei WangMOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Nanjing University, 12 Xuefu Road, Pukou High-tech Development Zone, Nanjing, 210061, People's Republic of China.
Xiaohua DongMOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Nanjing University, 12 Xuefu Road, Pukou High-tech Development Zone, Nanjing, 210061, People's Republic of China.
Zheng XiangDepartment of Pharmacology, Jinling Hospital, School of Medicine, Nanjing University, No. 305 Zhongshan East Road, Nanjing, 210002, People's Republic of China.
Kai LiCollege of Pharmaceutical Science, Soochow University, No. 199, Renai Road, Suzhou, 215123, People's Republic of China.
Minsheng ZhuMOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Nanjing University, 12 Xuefu Road, Pukou High-tech Development Zone, Nanjing, 210061, People's Republic of China. zhums@nicemice.cn.
Qingshun ZhaoMOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Nanjing University, 12 Xuefu Road, Pukou High-tech Development Zone, Nanjing, 210061, People's Republic of China. qingshun@nju.edu.cn.
Guohua ZhouDepartment of Pharmacology, Jinling Hospital, School of Medicine, Nanjing University, No. 305 Zhongshan East Road, Nanjing, 210002, People's Republic of China. ghzhou@nju.edu.cn.
Nanjing University · CNModel Animal Research Center · CNState Key Laboratory of Pharmaceutical BiotechnologySoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engineered endonucleases are a powerful tool for editing DNA. However, sequence preferences may limit their application. We engineer a structure-guided endonuclease (SGN) composed of flap endonuclease-1 (FEN-1), which recognizes the 3' flap structure, and the cleavage domain of Fok I (Fn1), which cleaves DNA strands. The SGN recognizes the target DNA on the basis of the 3' flap structure formed between the target and the guide DNA (gDNA) and cut the target through its Fn1 dimerization. Our results show that the SGN, guided by a pair of gDNAs, cleaves transgenic reporter gene and endogenous genes in zebrafish embryonic genome.

Indexed as

Gene EditingAnimalsBase SequenceDeoxyribonucleases, Type II Site-SpecificDNADNA, Single-StrandedEndodeoxyribonucleasesFlap EndonucleasesGene TargetingModels, BiologicalMutationSequence Analysis, DNASubstrate SpecificityZebrafishDeoxyribonucleases, Type II Site-SpecificDNADNA, Single-Strandedendodeoxyribonuclease FokIEndodeoxyribonucleasesFlap EndonucleasesDNA editingflap endonuclease-1 (FEN-1)Fok IGuide DNAStructure-guided endonuclease

Identifiers

PMID27634179
PMCPMC5025552
OpenAlexW2520968967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.